Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pacific Biosciences
(NQ:
PACB
)
1.800
+0.140 (+8.43%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pacific Biosciences
< Previous
1
2
3
4
5
6
7
Next >
Mid-Day Market Update: Crude Oil Rises 3.5%; Pacific Biosciences of California Shares Fall
January 11, 2022
Midway through trading Tuesday, the Dow traded down 0.50% to 35,889.26 while the NASDAQ fell 0.16% to 14,919.61. The S&P also fell, dropping, 0.39% to 4,652.01. The U.S. has...
Via
Benzinga
30 Stocks Moving In Tuesday's Mid-Day Session
January 11, 2022
Gainers TSR, Inc. (NASDAQ: TSRI) shares climbed 36.6% to $12.21 following Q2 results. The company reported Q2 revenue of $23.9 million, versus $16.1 million year over year....
Via
Benzinga
The Daily Biotech Pulse: Illunina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In
January 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus BioAtla, Bristol-Myers Squibb Announce Collaboration To Evaluate ADC-Opdivo...
Via
Benzinga
Earnings Scheduled For November 2, 2021
November 02, 2021
Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion. •...
Via
Benzinga
52 Weeks High And Low Article
January 11, 2022
Stocks that Broke Yearly Lows Tuesday Morning During Tuesday's morning trading, 87 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Highs And Lows: 10x...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 11, 2022
Gainers Black Diamond Therapeutic (NASDAQ:BDTX) stock increased by 18.2% to $5.32 during Tuesday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
January 11, 2022
Grab a cup of coffee and get ready for another busy day of trading as we start with the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
21 Stocks Moving in Tuesday's Pre-Market Session
January 11, 2022
Gainers OneSmart International Education Group Limited (NYSE: ONE) rose 39.1% to $0.2701 in pre-market trading. OneSmart International Education Group received notification from...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 10, 2022
Gainers Inari Medical (NASDAQ:NARI) stock...
Via
Benzinga
Biotech Playbook 2021 Part 2: Rotation Rally Brings Relief after FED Pivot
December 22, 2021
The new aggressive Fed taper combined with a rise in interest rates for 2022 adds a new element of risk to portfolio management. Monetary policy is a headwind for 2022.
Via
Talk Markets
Looking for Growth in Small and Mid Cap Life Science Stocks
November 15, 2021
2021 is an unusual year for biotech with a “blow-off” February high in speculative small caps.
Via
Talk Markets
Pacific Biosciences Q3 Revenues Jump 83%, Says Sequel II/IIe Installations At All-Time High
November 03, 2021
Pacific Biosciences of California Inc (NASDAQ: PACB) reported Q3 sales of $34.9 million, beating the consensus of $33.23 million and up 83% Y/Y. The company...
Via
Benzinga
Pacific Biosciences of California (PACB) Q3 2021 Earnings Call Transcript
November 03, 2021
PACB earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares...
Via
Benzinga
Exposures
COVID-19
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
3 Genomics Stocks That Could Soar 60% or Better, According to Wall Street
October 27, 2021
The genomic revolution is upon us and these stocks could be great vehicles for investors who want to take advantage of it.
Via
The Motley Fool
Class Of 2010: A Decade After Their IPOs, Where Are These Companies Now?
October 10, 2021
The year 2010 was a bumper year for IPOs, as more than twice as many new issues were floated as compared to the previous year. The IPO boom of the year was spearheaded by special purpose acquisition...
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Class Of 2010: A Decade After Their IPOs, Where Are These Companies Now?
October 10, 2021
Initial public offerings provide companies with the wherewithal to pursue growth opportunities without having to bear the burden of repayment. What Is an IPO: An IPO is a...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
5 Largest US M&A Deals In Q2: Railways, Health Care, REITS And More
September 06, 2021
The second quarter started strong with four of the five largest deals announced in the month of April.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2021
September 27, 2021
Upgrades According to Roth Capital, the prior rating for Seelos Therapeutics Inc (NASDAQ:
Via
Benzinga
5 Largest US M&A Deals In Q2: Railways, Health Care, REITS And More
September 06, 2021
Global merger and acquisition activity topped $1 trillion in the second quarter of 2021, with the U.S alone topping $500 billion. This was the third quarter in a row that this...
Via
Benzinga
Week In Review: China Life Science Posts $1.3 Billion In Deals
August 07, 2021
Pacific Biosciences, a San Francisco Bay area company offering long-read sequencing platforms, will acquire Omniome for up to $800 million. Zai Lab and Schrödinger formed a collaboration to develop a...
Via
Talk Markets
Billionaire Masayoshi Son's SoftBank Claims $5B Stake In Roche: Bloomberg
August 04, 2021
SoftBank Group Corp (OTC: SFTBF) has quietly acquired a $5 billion stake in Roche Holdings AG (OTC: RHHBF), making it one of the largest investors of the Roche,...
Via
Benzinga
Pacific Biosciences of California (PACB) Q2 2021 Earnings Call Transcript
August 04, 2021
PACB earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Pacific Biosciences Q2 Earnings Beat Expectations, Higher Operating Costs Widens Quarterly Loss
August 04, 2021
Pacific Biosciences of California Inc (NASDAQ: PACB), after the close of the market on Tuesday, reported Q2 sales of $30.6 million, beating the consensus of $29.9...
Via
Benzinga
Topics
Earnings
Exposures
Financial
$5,000 Invested in These 3 Healthcare Stocks Could Make You Rich Over the Next 10 Years
August 04, 2021
These companies could upend the industry in the years ahead.
Via
The Motley Fool
Earnings Scheduled For August 3, 2021
August 03, 2021
Companies Reporting Before The Bell • Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter. • Stellantis (NYSE:STLA) is expected to...
Via
Benzinga
Pacific Biosciences To Buy DNA Sequencing Firm For Up To $800M, Announces $300M Capital Raise For Deal Funding
July 20, 2021
Pacific Biosciences of California Inc (NASDAQ: PACB) has agreed to acquire Omniome, a San Diego-based company developing a short-read sequencing platform. Under...
Via
Benzinga
This Biotech Just Made History. Will Its Stock Follow?
June 04, 2021
Twenty years after the human genome was sequenced, a new wave of discovery has begun.
Via
The Motley Fool
2 Winners for a Drug Development Future That Looks Nothing Like the Past
June 04, 2021
A new breed of disruptors is delivering breakthroughs in genomics.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.